Chen et al. developed a bio-responsive fibrin gel solution, containing CD47-conjugated nanoparticles as a post-surgical tool to induce the local phagocytosis of cancer cells and modulate an innate and adaptive immune response [120]. The gene discussed is CD47; the disease is cancer.